Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Longhurst

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Clinical Reviews in Allergy & Immunology|January 14, 2021
Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 GeneJyoti Sharma, Ankur Kumar Jindal, Aaqib Zaffar Banday, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 28, 2021
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Health and Quality of Life Outcomes|July 2, 2015
Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studiesNicola Bonner, Linda Abetz-Webb, Lydie Renault, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Clinical Immunology (Orlando, Fla.)|November 29, 2017
A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID)Mark A Russell, Manuela Pigors, Maha E Houssen, et al.
Helicobacter|May 12, 2007
Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedemaBeáta Visy, George Füst, Anette Bygum, et al.
Plos One|February 8, 2013
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatmentMarcus Maurer, Werner Aberer, Laurence Bouillet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
International Archives of Allergy and Immunology|June 27, 2015
Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care ProfessionalsDolores Hernández Fernandez de Rojas, Ethel Ibañez, Hilary Longhurst, et al.
Expert Review of Clinical Immunology|March 22, 2021
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infectionRohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Clinical Reviews in Allergy & Immunology|January 14, 2021
Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 GeneJyoti Sharma, Ankur Kumar Jindal, Aaqib Zaffar Banday, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 28, 2021
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19Rohan Ameratunga, Hilary Longhurst, Richard Steele, et al.
Health and Quality of Life Outcomes|July 2, 2015
Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studiesNicola Bonner, Linda Abetz-Webb, Lydie Renault, et al.
Journal of Immunological Methods|May 29, 2025
Reference intervals for functional lymphocyte proliferation studies using <sup>3</sup>H thymidine uptake in adultsRohan Ameratunga, Danny Lim, Hilary Longhurst, et al.
Clinical Immunology (Orlando, Fla.)|November 29, 2017
A novel de novo activating mutation in STAT3 identified in a patient with common variable immunodeficiency (CVID)Mark A Russell, Manuela Pigors, Maha E Houssen, et al.
Helicobacter|May 12, 2007
Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedemaBeáta Visy, George Füst, Anette Bygum, et al.
Plos One|February 8, 2013
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatmentMarcus Maurer, Werner Aberer, Laurence Bouillet, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 14, 2022
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19Rohan Ameratunga, Euphemia Leung, See-Tarn Woon, et al.
International Archives of Allergy and Immunology|June 27, 2015
Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care ProfessionalsDolores Hernández Fernandez de Rojas, Ethel Ibañez, Hilary Longhurst, et al.
Expert Review of Clinical Immunology|March 22, 2021
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infectionRohan Ameratunga, See-Tarn Woon, Anthony Jordan, et al.
Pageof 8